References
1. Javitt JC, et al. Cataract and latitude. Doc Ophthalmol
1994-95;88(3-4):307-25.
2. Ariturk N, et al. Secondary glaucoma after congenital
cataract surgery. Int Ophthalmol 1998-99;22(3):175-80.
3. Spierer A, et al. Secondary glaucoma after congenital
cataract surgery. [Article in Hebrew] Harefuah 1994 Jun
1;126(11):645-7, 691.
4. Svacova H, et al. Retinal detachment in pseudophakia.
[Article in Slovak] Cesk Oftalmol 1991 Mar;47(2):98-104.
5. Marty N, et al. Epidemiology of nosocomial infections after
cataract surgery and role of the Infection Control Committee in
prevention. [Article in French] Bull Acad Natl Med
2002;186(3):635-45; discussion 645-8.
6. Carlson AN, et al. Infectious complications of modern
cataract surgery and intraocular lens implantation. Infect Dis
Clin North Am 1989 Jun;3(2):339-55.
7. Chercota V. Corneal edema, a complication of cataract
surgery. [Article in Romanian] Oftalmologia 1995
Oct-Dec;39(4):343-8.
8. Lumme P, et al. Risk factors for intraoperative and early
postoperative complications in extracapsular cataract surgery.
Eur J Ophthalmol 1994 Jul-Sep;4(3):151-8.
9. Obuchowska I, et al. The evaluation of incidence of massive
suprachoroidal hemorrhage in the material of the Department of
Ophthalmology, Medical Academy in Bialystok from 1990 to 2000.
[Article in Polish] Klin Oczna 2002;104(2):93-5.
10. Jacques PF, et al. Long-term nutrient intake and early
age-related nuclear lens opacities. Arch Ophthalmol 2001 Jul;
119(7):1009-19.
11. Cumming RG, et al. Diet and cataract: the Blue Mountains Eye
Study. Ophthalmology 2000 Mar; 107(3):450-6.
12. Babizhayev MA, et al. Lipid peroxide and reactive oxygen
species generating systems of the crystalline lens. Biochim
Biophys Acta 1994 Feb 22; 1225(3):326-37.
13. Wang AM, et al. Use of carnosine as a natural
anti-senescence drug for human beings. Biochemistry (Mosc) 2000
Jul; 65(7):869-71.
14. Quinn PJ, et al. Carnosine: its properties, functions and
potential therapeutic applications. Mol Aspects Med 1992;
13(5):379-444.
15. Specht S, et al. Continuing damage to rat retinal DNA during
darkness following light exposure. Photochem Photobiol 2000;
71(5):559-66.
16. Lou MF. Thiol regulation in the lens. J Ocul Pharmacol Ther
2000 Apr; 16(2):137-48.
17. Wang AM, et al. Use of carnosine as a natural
anti-senescence drug for human beings. Department of
Biochemistry and Department of Neurobiology, Harbin Medical
University, China 1999.
18. Babizhayev M, et al. Efficacy of N-acetylcarnosine in the
treatment of cataracts. Drugs Research & Development 2002;
3(2):87-103.
19. Giblin FJ. Glutathione: a vital lens antioxidant. J Ocul
Pharmacol Ther 2000 Apr; 16(2):121-35.
20. Kamei A. Glutathione levels of the human crystalline lens in
aging and its antioxidant effect against the oxidation of lens
proteins. Biol Pharm Bull 1993; 16(9); 170-5.
21. Devamanorharan PS, et al. Oxidative stress to rat lens in
vitro: protection by taurine. Free Radic Res 1998 Sep; 29(3):
189-95.
22. Hockwin O. The medical treatment of senile cataract in man:
a controlled clinical study on the efficacy of a preparation.
Institute for Experimental Ophthalmology, Bonn University, Fed
Republic of Germany, Oct 2, 1978 to July 8, 1980.
23. Hockwin O, Ophthalmic Research, 1978, 10 (5-6): 250-8.
24. Oguchi M, et al. Glutathione and eye diseases. Ganka, 1970;
12: 125-32.
25. Fujii S, et al. Effects of an eye drop solution, tathion, on
cataract. Nippon Ganka Kiyo 1968; 19:136-42.
26. Kandori F, et al. Clinical use of topical glutathione for
cataract. Nippon Ganka Gakkai Zasshi 1967; 71: 689-97.
27. Mitton KP, et al. Modelling cortical cataractogenesis 21: in
diabetic rat lenses taurine supplementation partially reduces
damage resulting from osmotic compensation leading to osmolyte
loss and antioxidant depletion. Exp Eye Res 1999 Sep; 69(3):
279-89.
28. Killic F, et al. Modelling cortical cataractogenesis 22: is
in vitro reduction of damage in model diabetic rat cataract by
taurine due to its antioxidant activity? Exp Eye Res 1999 Sep;
69(3):291-300.]
29. Devamanoharan PS, et al. Oxidative stress to rat lens in
vitro: protection by taurine. Free Radic Res 1998
Sep;29(3):189-95.
30. Brubaker RF, et al. Ascorbic acid content of human corneal
epithelium. Invest Ophthalmol Vis Sci 2000 Jun;41(7):1681-3
31. Hankinson SE, et al. Nutrient intake and cataract extraction
in women: a prospective study. BMJ 1992 Aug 8;305(6849):335-9
32. Mares-Perlman JA, et al. Vitamin supplement use and incident
cataracts in a population-based study. Arch Ophthalmol 2000
Nov;118(11):1556-63.
33. Robertson JMcD. A possible role for vitamins C and E in
cataract prevention. Am J Clin Nutr 1991; 53:346S-351S.
34. Taylor A, et al. Long-term intake of vitamins and
carotenoids and odds of early age-related cortical and posterior
subcapsular lens opacities. Am J Clin Nutr 2002 Mar;75(3):540-9.
35. News from the AAO: New Study Indicates Nutrition May Play
Greater Role in Preventing Cataracts. press release from the
American Academy of Ophthalmology, March 10, 2000.
36. Kuzniarz M, et al. Use of vitamin supplements and cataract:
the Blue Mountains Eye Study. Am J Ophthalmol 2001
Jul;132(1):19-26.
37. Detcho A, et al. Endogenous ascorbate regenerates vitamin E
in the retina directly and in combination with exogenous
dihydrolipoic acid. Curr Eye Res 1994; 181-9.
38. Robertson JMcD, et al. Vitamin E intake and risk of cataract
in humans. Ann NY Acad Sci 1993; 372-82.
39. Olmedilla B, et al. Serum status of carotenoids and
tocopherols in patients with age-related cataracts: a
case-control study. J Nutr Health Aging 2002;6(1):66-8.
40. Campisi A, et al. Antioxidant systems in rat lens as a
function of age: effect of chronic administration of vitamin E
and ascorbate. Aging (Milano) 1999 Feb; 11(1):39-43.
41. Ayalasomayajula SP, et al. Induction of vascular endothelial
growth factor by 4-hydroxynonenal and its prevention by
glutathione precursors in retinal pigment epithelial cells. Eur
J Pharmacol 2002 Aug 9;449(3):213-20.
42. Seddon JM, et al. Dietary carotenoids, vitamins A, C and E,
and advanced age-related macular degeneration. Eye Disease
Case-Control Study Group. JAMA 1994 Nov 9;272(18):1413-20.
43. Delcourt C, et al. Age-related macular degeneration and
antioxidant status in the POLA study. POLA Study Group,
Pathologies Oculaires Liees a l'Age. Arch Ophthalmol 1999
Oct;117(10):1384-90.
44. Wegener A, et al. Experimental evidence for interactive
effects of chronic UV irradiation and nutritional deficiencies
in the lens. Dev Ophthalmol 2002; 35:113-24.
45. Popova ZS, et al. Treatment of primary open-angle glaucoma
by the method of combimed use of hyperbaric oxygenation and
antioxidants. Vestn Oftalmol 1996 Jan-Mar;112(1):4-6.
46. Smith, Wayne, et al. Dietary fat and fish intake and
age-related maculopathy. Archives of Ophthalmology, Vol. 118,
March 2000, pp. 401-04
47. Johanna M. Seddon; Gary Gensler; Roy C. Milton; Michael L.
Klein; Nader Rifai. Association Between C-Reactive Protein and Age-Related
Macular Degeneration.
JAMA. 2004;291:704-710.
48. Cho, Eunyoung, et al. Prospective study of dietary fat and
the risk of age-related macular degeneration. American Journal
of Clinical Nutrition 2001;73:209-218.
49. Chibret H. Dry eyes syndrome: reality and perspectives of
treatment. Ann Pharm Fr 2002 Mar; 60(2):115-22.
50. Hammond BR, Jr., Johnson EJ, Russell RM, et al. Dietary
modification of human macular pigment density. Invest Ophthalmol
Vis Sci. 1997 Aug: 38(9): 1795-801.
51. Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE.
A one year study of the macular pigment: the effect of 140 days
of a lutein supplement. Exp Eye Res. 1997 Jul;65(1):57-62.
52. Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J,
van Norel J, van Noren D. Influence of lutein supplementation on
macular pigment, assessed with two objective techniques. Invest
Ophthalmol Vis Sci. 2000 Oct;41(11):3322-6.
53. Koh HH, Murray IJ, Nolan D, Carden D, Feather J, Beatty S.
Plasma and macular responses to lutein supplementation in
subjects with and without age-related maculopathy: a pilot
study. Exp Eye Res. 2004 Jul;79(1):21-7.
54. Trivedi KA. Omega-3 fatty acids reduce risk of dry eye syndrome. ARVO 2003 Annual Meeting: abstract 2112, presented May 6, 2003.
Return to Vision article
Adapted with permission from an article in Life Extension,
Feb 2003
